Results 311 to 320 of about 435,241 (348)

Clinical efficacy of rubella vaccine

The Pediatric Infectious Disease Journal, 1983
In the period October 10, 1980, to January 19, 1981, 83 cases of rash illness compatible with rubella were reported in Sanford, ME. Twenty-two (27%) were confirmed serologically. Forty cases (48%) occurred in Sanford High School students; the overall attack rate was 3.2%.
W L, Greaves, W A, Orenstein, A R, Hinman, W S, Nersesian   +3 more
openaire   +2 more sources

Vaccine Efficacy Studies

2020
This chapter focuses on the analysis of vaccine efficacy data. Special attention is given to the analysis of person-time or time-to-infection data. Four different approaches are presented, an exact one, two asymptotic ones (Poisson regression and Cox regression) and a new one, based on bootstrapping.
openaire   +1 more source

Efficacy of Pneumococcal Polysaccharide Vaccines

Clinical Infectious Diseases, 1981
due to pneumococcal infection. Estimates based on data obtained in this country after licensure of the vaccine suggest that the efficacy in certain groups may be low:
openaire   +2 more sources

Canine parvovirus vaccination efficacy

Veterinary Record, 1984
D G, Harper, L, Barnard
openaire   +2 more sources

Sensitivity, Specificity, and Vaccine Efficacy

Controlled Clinical Trials, 1998
We study the effects of imperfect sensitivity and specificity on estimation of vaccine efficacy (VE). We show that a specificity of
openaire   +2 more sources

Vaccine efficacy determination.

NIPH annals, 1992
The "Gold standard" in vaccine testing is the randomized, placebo controlled, double-blind efficacy trial. Once a protective immune mechanism is defined, e.g., from an efficacy trial, vaccine performance can then be judged by serologic parameters. Although immunogenicity studies can provide important information, in many instances the answer has to ...
openaire   +1 more source

Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

Nature Reviews Immunology, 2021
John S Tregoning, Ziyin Wang, Benjamin F Pierce   +2 more
exaly  

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2021
Hana M El Sahly, Karen L Kotloff, David J Diemert   +2 more
exaly  

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Lancet, The, 2021
Katherine R W Emary, Tanya Golubchik, Brian J Angus   +2 more
exaly  

Efficacy of Rotavirus Vaccines

Pediatric Infectious Disease Journal
Stanley A, Plotkin, Paul, Offit
openaire   +2 more sources